USANA Health Sciences (NYSE:USNA) Stock Price Down 6% – Should You Sell?

USANA Health Sciences, Inc. (NYSE:USNA) was down 6% during trading on Friday . The company traded as low as $33.00 and last traded at $32.77. Approximately 68,031 shares traded hands during mid-day trading, a decline of 41% from the average daily volume of 116,075 shares. The stock had previously closed at $34.86.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on USNA shares. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 28th. DA Davidson upped their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a report on Thursday, January 2nd.

USANA Health Sciences Stock Down 6.5 %

The firm has a fifty day simple moving average of $35.90 and a 200-day simple moving average of $38.06. The company has a market capitalization of $621.17 million, a P/E ratio of 11.52, a P/E/G ratio of 0.94 and a beta of 0.89.

Insiders Place Their Bets

In related news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. R Squared Ltd bought a new position in shares of USANA Health Sciences during the fourth quarter worth about $28,000. Safe Harbor Fiduciary LLC bought a new position in shares of USANA Health Sciences during the third quarter worth about $30,000. KBC Group NV boosted its position in USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares during the last quarter. Centiva Capital LP acquired a new position in USANA Health Sciences during the third quarter valued at approximately $213,000. Finally, Quest Partners LLC acquired a new position in USANA Health Sciences during the third quarter valued at approximately $250,000. 54.25% of the stock is currently owned by institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.